HighTower Advisors’s NanoViricides NNVC Stock Holding History

HighTower Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,071	Closed	-$4K	–	2498
2019 Q2	$4K	Hold	1,071	–	–	﹤0.01%	2330
2019 Q1	$6K	Hold	1,071	–	–	﹤0.01%	2223
2018 Q4	$4K	Hold	1,071	–	–	﹤0.01%	2156
2018 Q3	$8K	Hold	1,071	–	–	﹤0.01%	2209
2018 Q2	$8K	Hold	1,071	–	–	﹤0.01%	2155
2018 Q1	$16K	Hold	1,071	–	–	﹤0.01%	2065
2017 Q4	$18K	Hold	1,071	–	–	﹤0.01%	2163
2017 Q3	$24K	Hold	1,071	–	–	﹤0.01%	2119
2017 Q2	$31K	Buy	1,071 +300	+39%	+$7.41K	﹤0.01%	2050
2017 Q1	$17K	Buy	771 +100	+15%	+$2.33K	﹤0.01%	1979
2016 Q4	$15K	Hold	671	–	–	﹤0.01%	1874
2016 Q3	$23K	Buy	671 +100	+18%	+$3.31K	﹤0.01%	1819
2016 Q2	$19K	Sell	571 -98	-15%	-$3.58K	﹤0.01%	1684
2016 Q1	$29K	Hold	669	–	–	﹤0.01%	1982
2015 Q4	$16K	Sell	669 -107	-14%	-$2.56K	﹤0.01%	1963
2015 Q3	$19K	Buy	+776	New	+$20.5K	﹤0.01%	1831

Other funds holding NNVC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HighTower Advisors's NNVC Position: Q3 2019 in Review

HighTower Advisors sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 1,071 shares — an estimated $4K sold.

HighTower Advisors first reported a position in NNVC in Q3 2015 and held it in 16 quarters. The position peaked at $31K in Q2 2017. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

HighTower Advisors reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
HighTower Advisors sold 1,071 NanoViricides shares in Q3 2019, an estimated $4K.
HighTower Advisors first reported a position in NanoViricides in Q3 2015 and held it in 16 quarters.
HighTower Advisors's NanoViricides position peaked at $31K in Q2 2017.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on HighTower Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.